AG
CGEM icon

Algert Global’s Cullinan Oncology CGEM Stock Holding History

Algert Global’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
36,851
-72,880
-66% -$1.08M 0.01% 1028
2026
Q1 		$1.56M Sell
109,731
-52,770
-32% -$678K 0.02% 765
2025
Q4 		$1.68M Sell
162,501
-73,591
-31% -$664K 0.03% 752
2025
Q3 		$1.4M Buy
236,092
+20,512
+10% +$150K 0.02% 775
2025
Q2 		$1.62M Sell
215,580
-5,850
-3% -$47K 0.03% 692
2025
Q1 		$1.68M Buy
221,430
+178,138
+411% +$1.71M 0.04% 651
2024
Q4 		$527K Buy
43,292
+3,408
+9% +$49K 0.01% 896
2024
Q3 		$668K Hold
39,884
– – 0.02% 840
2024
Q2 		$696K Sell
39,884
-39,796
-50% -$847K 0.02% 784
2024
Q1 		$1.36M Buy
79,680
+38,660
+94% +$597K 0.05% 537
2023
Q4 		$418K Buy
41,020
+24,480
+148% +$217K 0.02% 870
2023
Q3 		$150K Buy
+16,540
New +$172K 0.01% 994

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Algert Global's CGEM Position: Q2 2026 in Review

Algert Global reduced its Cullinan Oncology (CGEM) stake by 66% in Q2 2026, selling an estimated $1.08M and leaving 36,851 shares worth $671K. The position accounts for 0.01% of the portfolio, ranked #1028.

Algert Global first reported a position in CGEM in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.68M in Q4 2025. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Algert Global held 36,851 shares of Cullinan Oncology worth $671K as of Q2 2026.
  • Algert Global sold 72,880 Cullinan Oncology shares in Q2 2026, an estimated $1.08M.
  • Cullinan Oncology made up 0.01% of Algert Global's portfolio in Q2 2026, its #1028 holding.
  • Algert Global first reported a position in Cullinan Oncology in Q3 2023 and has held it in 12 quarters since.
  • Algert Global's Cullinan Oncology position peaked at $1.68M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.